About.com taps WebMD for health exec

Share this article:
About.com upped the ante on its health offering, bringing on Marjorie Martin from archrival WebMD to head About Health (health.about.com). 

Martin, who started out as a TV news correspondent and spent eight years at WebMD, most recently as VP and managing director, is charged with adding features and plotting strategy to expand and differentiate the site. She reports to COO Andrew Pancer. 

With 4.9 million unique visitors in March, according to Nielsen Net Ratings, About Health lags behind WebMD (22.6 million) and MSN Health (5.7 million), but leads both AOL Health (4 million) and Yahoo! Health (2.8 million). 

About.com president and CEO Scott Meyer said the site is the strongest of the About.com properties, recently bought by The New York Times Company, and that the firm sought to leverage its expertise and original content to pull ahead of the portals.

“What we really have is two sites [About and WebMD] publishing quality original content, and the portals are really just aggregating content from elsewhere,” said Meyer. About Health, he said, projects the “voice of reason,” with credentialed expert guides trained by the company and paid based on the traffic their sites generate. 

Meyer said the sector had seen sharp growth in online advertising spending recently, from pharmas as well as from device manufacturers and consumer packaged-goods companies.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...